Position in ABBV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,797,603,407
+$992,083,789 QoQ
Shares Held
31,254,786
+23.0% QoQ
Ownership
1.77%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.95915505548494.ToString("F0")%
Shared 0.ToString("F0")%
None 0.04084494451505763.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital Research Global Investors holds $39,059,483,079 across 9 Drug Manufacturers - General names. ABBV ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
24,632,647 | $22,656,369,731 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
31,254,786 | $6,797,603,407 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
27,127,533 | $3,780,764,274 | |
| 4 | AMGN |
Amgen Inc
|
6,955,345 | $2,447,238,138 | |
| 5 | JNJ |
Johnson & Johnson
|
8,739,988 | $2,136,402,666 | |
| 6 | AZN |
Astrazeneca PLC
|
4,611,176 | $909,416,130 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,061,571 | $247,986,375 | |
| 8 | SNY |
Sanofi
|
1,661,837 | $80,067,306 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,797,603,407 | 31,254,786 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,805,519,618 | 25,408,200 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,841,946,378 | 25,230,830 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,689,796,773 | 25,265,579 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $7,020,599,093 | 33,508,014 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $6,038,904,733 | 33,983,707 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,557,438,135 | 33,205,581 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,691,958,778 | 33,185,394 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,698,846,815 | 31,295,150 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,696,002,290 | 30,302,654 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,766,364,024 | 31,976,144 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,384,858,179 | 32,545,522 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,691,798,668 | 35,714,367 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,932,992,220 | 36,711,789 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,857,476,219 | 36,193,102 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,027,528,595 | 26,296,217 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,768,873,005 | 17,080,211 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $2,437,989,246 | 18,005,829 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,050,599,099 | 19,009,911 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,104,730,890 | 18,685,466 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,188,277,552 | 20,220,639 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,063,241,793 | 37,921,062 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,574,032,257 | 40,804,113 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,526,460,186 | 46,103,689 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,751,009,317 | 49,232,305 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||